Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT’s Therapeutic Vector Evolution platform to invent ...

There has been an increasing number of successful gene therapy clinical trials, leading to regulatory approvals of numerous gene therapy products, in particular ones based on the adeno-associated ...

A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile ...

Physician-researchers with City of Hope have developed a way to add features to T cells to help them overcome mechanisms of ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Krystal Biotech (KRYS – Research Report) yesterday and set a price ...

Malaria claims almost 600,000 lives annually. Novel vector control, expanded use of preventive medicines, and newly ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...

The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal ...

Just three months after its launch, Gemma Biotherapeutics is planning to expand operations with $34 million in fresh funding.

Atropos Health, a leader in translating clinical data into high-quality, personalized, real-world evidence (RWE) for care, today announced the availab ...

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope ...